Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
54.62
+2.84 (5.48%)
At close: Nov 6, 2026, 4:00 PM EST
56.32
+1.70 (3.11%)
After-hours: Nov 6, 2026, 7:30 PM EST

Vericel Revenue

Vericel had revenue of $85.37M in the quarter ending September 30, 2026, with 26.47% growth. This brings the company's total for the last twelve months to $324.17M, up 25.30% year-over-year. In the year 2025, Vericel had annual revenue of $276.26M with 16.45% growth. That makes Vericel the 13,987th largest company in the world by revenue and 2,566th in the United States.

Revenue (ttm)
$324.17M
Revenue Growth
+25.30%
P/S Ratio
8.60
Revenue / Employee
$814,500
Employees
398
Market Cap
2.79B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025276.26M39.04M16.45%
Dec 31, 2024237.22M39.71M20.10%
Dec 31, 2023197.52M33.15M20.17%
Dec 31, 2022164.37M8.18M5.24%
Dec 31, 2021156.18M32.01M25.77%
Dec 31, 2020124.18M6.33M5.37%
Dec 31, 2019117.85M26.99M29.71%
Dec 31, 201890.86M26.93M42.13%
Dec 31, 201763.92M9.54M17.54%
Dec 31, 201654.38M3.22M6.28%
Dec 31, 201551.17M22.37M77.69%
Dec 31, 201428.80M28.78M151,457.89%
Dec 31, 201319.00K-2.00K-9.52%
Dec 31, 201221.00K3.00K16.67%
Dec 31, 201118.00K-71.00K-79.78%
Jun 30, 201089.00K-93.00K-51.10%
Jun 30, 2009182.00K-340.00K-65.13%
Jun 30, 2008522.00K-163.00K-23.80%
Jun 30, 2007685.00K-178.00K-20.63%
Jun 30, 2006863.00K-46.00K-5.06%
Jun 30, 2005909.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
ADMA Biologics519.15M
Zai Lab441.73M
Xencor200.49M
Beam Therapeutics146.64M
Arcus Biosciences100.00M
IDEAYA Biosciences36.54M
NewAmsterdam Pharma Company25.94M
Revenue Rankings